Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine

The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. F...

Full description

Saved in:
Bibliographic Details
Published inJournal of Neural Transmission Vol. 113; no. 1; pp. 1 - 10
Main Authors Atalla, A, Kuschinsky, K
Format Journal Article
LanguageEnglish
Published Austria Springer Nature B.V 01.01.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(omega)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS.
AbstractList The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(omega)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS.
The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between associative and non-associative type of sensitization might be relevant for possible differences in drug effects on sensitization phenomena. Furthermore, blockade of NMDA receptors might lead to an inhibition of NO-synthesis, and, accordingly, both of these effects might influence sensitization phenomena in a similar way. Male Wistar rats were sensitized to morphine by administrations of 3 mg/kg of morphine i.p. on day 1, 3, 5, and 7 and saline on days 2, 4, and 6. In part of the animals, the administration of morphine was performed in association with conditional stimuli, CS (test cage plus an auditory and an olfactory stimulus), in the other part not (pseudoconditioned, PCS). On day 17, the sensitization was more pronounced in the CS than the PCS group. The effects of dizocilpine (MK-801; 0.1 mg/kg i.p.), a blocker of NMDA glutamate receptors, or of L-NAME (N(G)-nitro-L-arginine methylester; 10 mg/kg i.p.), a non-specific inhibitor of NO synthase and the effect of N(ω)-propyl-L-arginine (20 mg/kg i.p.), a specific inhibitor of neuronal NO synthase, on expression or development of sensitization to morphine was studied. Neither MK-801 nor L-NAME influenced the development of associative and non-associative behavioural sensitization to morphine. The expression of sensitization to morphine was not influenced by MK-801. L-NAME inhibited the expression of associative, but not of non-associative sensitization. Surprisingly, inhibition of neuronal NO synthase, did not influence the expression of associative sensitization. We suggest that NMDA receptors were not involved in development or expression of both types of sensitization. Furthermore, the manifestation of the associative, but not the non-associative sensitization to morphine appeared to be dependent on a type of NO synthase, which is not the neuronal NO synthase, but probably the inducible NOS.
Author Kuschinsky, K
Atalla, A
Author_xml – sequence: 1
  givenname: A
  surname: Atalla
  fullname: Atalla, A
  organization: Institute of Pharmacology and Toxicology, Faculty of Pharmacy, University of Marburg, Marburg, Germany
– sequence: 2
  givenname: K
  surname: Kuschinsky
  fullname: Kuschinsky, K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15843868$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFB2CDLBbsAtd2HCfLqpQWqT-bdm059g2TksTBdiqGR-PpcDQjgdjUC_8cf-faV-eEHE1-QkLeMvjIANSnmCfgBYAsgDd1AS_IhpVCFqysxBHZgAAoGlmVx-QkxkcAYEzVr8gxk3Up6qrekN8XXYc2Reo72g7efjcO1_23YUlmNAnp7c3nMxrQ4px8yFxYr2_vaNxNaWtipieatkgdPuHg5xGntEKrhD_ngDH2mcgeE6O3vUn9E65A7qX4V4o4xT71v_Jprehp_o0ffX6UGpuJvd7u6OjDvO0nfE1edmaI-OawnpKHLxf351fF9d3l1_Oz68IKqVLRKoFgVAd11bZllUfrmOTYuAawrMDYTrm2EaypWu6UdRYdF7VtFK94hyhOyYd93Tn4HwvGpMc-WhwGM6Ffoq6UrGuu5LMga7hSvCwz-P4_8NEvYcpNaJ4DEg2TK8T2kA0-xoCdnkM_mrDTDPQav97Hr3P8eo1fQ_a8OxRe2hHdX8chb_EHMaCxIA
CODEN JNTRF3
CitedBy_id crossref_primary_10_1007_s00213_011_2354_9
crossref_primary_10_1016_j_biopsych_2013_04_026
crossref_primary_10_1016_j_pnpbp_2014_11_004
crossref_primary_10_1111_j_1471_4159_2007_04811_x
crossref_primary_10_1016_j_bbr_2009_09_016
crossref_primary_10_1016_j_ejphar_2010_11_037
crossref_primary_10_1016_j_ejphar_2006_11_067
crossref_primary_10_1016_j_yebeh_2010_12_020
crossref_primary_10_1002_syn_21503
crossref_primary_10_1016_j_neulet_2009_08_017
crossref_primary_10_1007_s00213_007_0984_8
crossref_primary_10_1111_1440_1681_13779
crossref_primary_10_1016_j_ejphar_2020_173274
crossref_primary_10_1007_s00213_009_1687_0
crossref_primary_10_1016_j_ejphar_2006_10_044
crossref_primary_10_1007_s11064_010_0325_x
crossref_primary_10_1016_j_brainres_2009_06_100
crossref_primary_10_1111_jnc_14952
crossref_primary_10_1002_syn_20440
Cites_doi 10.1007/s00702-002-0791-7
10.1016/j.ejphar.2004.09.042
10.1002/syn.890140307
10.1007/s002130000493
10.1016/0197-0186(82)90055-9
10.1007/s002130000447
10.1016/0006-8993(89)91140-2
10.1002/syn.890160207
10.1016/S0306-4522(01)00483-3
10.1523/JNEUROSCI.14-12-07415.1994
10.1016/S0014-2999(02)02696-1
10.1016/0024-3205(81)90157-0
10.1007/s002100000287
10.1002/syn.10076
10.1016/j.ejphar.2003.10.006
10.1016/S0031-9384(01)00588-1
10.1016/S0014-2999(02)02038-1
10.1016/S0301-0082(97)00090-7
10.1016/0028-3908(75)90129-X
10.1007/PL00004979
10.1007/s00210-003-0855-8
10.1016/0306-4522(96)00313-2
10.1002/syn.890050104
ContentType Journal Article
Copyright Springer-Verlag/Wien 2006
Copyright_xml – notice: Springer-Verlag/Wien 2006
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7TK
7X8
DOI 10.1007/s00702-005-0298-0
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
MEDLINE
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1435-1463
EndPage 10
ExternalDocumentID 947457631
10_1007_s00702_005_0298_0
15843868
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID -53
-BR
1SB
28-
29L
29~
3SX
40D
40E
5QI
5RE
95-
95.
95~
ABMNI
AEFIE
AGWIL
ALMA_UNASSIGNED_HOLDINGS
BBWZM
CGR
CUY
CVF
ECM
EIF
F5P
LAS
NPM
O93
O9G
O9I
O9J
P19
QOK
RHV
RNI
ROL
RZK
SDE
SOJ
WK6
~EX
AAYXX
CITATION
---
-5E
-Y2
.86
06D
0R~
0VY
1N0
203
30V
36B
4.4
53G
5VS
6NX
78A
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AAYIU
AAYQN
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABIVO
ABJOX
ABKCH
ABKTR
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACZOJ
ADHHG
ADHIR
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGXH
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AFLOW
AFWTZ
AFYQB
AFZKB
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHIZS
AHKAY
AHMBA
AHSBF
AIAGR
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJZVZ
AKMHD
ALWAN
AMKLP
AMTXH
AMXSW
AMYQR
AOCGG
ARMRJ
AXYYD
AZFZN
BDATZ
BGNMA
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EPAXT
ESBYG
FERAY
FFXSO
FIGPU
FINBP
FRRFC
FSGXE
FWDCC
GGCAI
GGRSB
GJIRD
GNWQR
H13
HF~
HG5
HMJXF
HQYDN
HRMNR
HZ~
I09
IHE
IKXTQ
IWAJR
IZIGR
IZQ
I~X
J0Z
JBSCW
JCJTX
JZLTJ
K9.
LLZTM
M4Y
N2Q
N9A
NPVJJ
NQJWS
NU0
O9-
OVD
P2P
PQQKQ
PT4
PT5
R9I
RPX
SCLPG
SDM
SISQX
SJYHP
SNPRN
SOHCF
SPISZ
SRMVM
SSLCW
SSXJD
SV3
TEORI
TSK
TSV
TT1
UG4
UOJIU
UTJUX
UZXMN
VFIZW
WJK
WK8
YLTOR
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z8W
Z91
ZMTXR
ZOVNA
7TK
7X8
ID FETCH-LOGICAL-c357t-b73e0a7f086bb46666bd152e9d90e460acf7db93196b2d7cdced238c97262fee3
ISSN 0300-9564
IngestDate Sat Oct 26 00:43:18 EDT 2024
Fri Oct 25 05:20:21 EDT 2024
Thu Oct 10 18:01:06 EDT 2024
Fri Aug 23 04:06:15 EDT 2024
Sat Sep 28 07:45:35 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-b73e0a7f086bb46666bd152e9d90e460acf7db93196b2d7cdced238c97262fee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15843868
PQID 217839154
PQPubID 51646
PageCount 10
ParticipantIDs proquest_miscellaneous_67588275
proquest_miscellaneous_19277244
proquest_journals_217839154
crossref_primary_10_1007_s00702_005_0298_0
pubmed_primary_15843868
PublicationCentury 2000
PublicationDate 2006-Jan
2006-1-00
20060101
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – month: 01
  year: 2006
  text: 2006-Jan
PublicationDecade 2000
PublicationPlace Austria
PublicationPlace_xml – name: Austria
– name: Wien
PublicationTitle Journal of Neural Transmission
PublicationTitleAlternate J Neural Transm (Vienna)
PublicationYear 2006
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
References 20487869 - Neurochem Int. 1982;4(4):199-215
15496304 - Eur J Pharmacol. 2004 Oct 25;503(1-3):103-7
1237099 - Neuropharmacology. 1975 Aug;14(8):611-4
7194958 - Life Sci. 1981 Feb 16;28(7):755-60
10997725 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):232-7
8211708 - Synapse. 1993 Jul;14(3):243-5
9109371 - Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):531-7
2679971 - Brain Res. 1989 Oct 9;499(1):108-20
12658363 - J Neural Transm (Vienna). 2003 Apr;110(4):353-62
8197575 - Synapse. 1994 Feb;16(2):137-47
7527843 - J Neurosci. 1994 Dec;14(12):7415-25
8951881 - Neuroscience. 1996 Dec;75(3):881-90
9560846 - Prog Neurobiol. 1998 Apr;54(6):679-720
12498915 - Eur J Pharmacol. 2003 Jan 1;458(1-2):119-28
11984858 - Synapse. 2002 Jun 15;44(4):227-45
11790403 - Physiol Behav. 2001 Nov-Dec;74(4-5):441-7
14673514 - Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):228-31
11801363 - Neuroscience. 2002;109(2):267-74
2300906 - Synapse. 1990;5(1):48-58
12167469 - Eur J Pharmacol. 2002 Aug 9;449(3):269-77
10972458 - Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
10972474 - Psychopharmacology (Berl). 2000 Aug;151(2-3):273-82
11224409 - Behav Pharmacol. 1996 Mar;7(2):169-184
14660024 - Eur J Pharmacol. 2003 Dec 15;482(1-3):205-13
MR Zarrindast (298_CR25) 2003; 482
I Afanas’ev (298_CR1) 2000; 362
A Badiani (298_CR3) 2000; 151
R Spanagel (298_CR19) 1993; 14
A Gholami (298_CR5) 2002; 449
ME Wolf (298_CR24) 1998; 54
U Havemann (298_CR9) 1982; 4
AR West (298_CR23) 2002; 44
TM Tzschentke (298_CR20) 1996; 7
RM Post (298_CR16) 1981; 28
S Scheggi (298_CR17) 2002; 109
A-K Lienau (298_CR13) 1997; 355
K Park (298_CR14) 2001; 74
DM Bannerman (298_CR4) 1994; 14
298_CR15
MT Silva (298_CR18) 2003; 110
A Gholami (298_CR6) 2003; 458
LJMJ Vanderschuren (298_CR21) 2000; 151
P Vezina (298_CR22) 1989; 499
M Jeziorski (298_CR10) 1994; 16
H Hara (298_CR8) 1996; 75
D Klamer (298_CR12) 2004; 503
M Babbini (298_CR2) 1975; 14
PW Kalivas (298_CR11) 1990; 5
M Grönig (298_CR7) 2004; 369
References_xml – volume: 110
  start-page: 353
  year: 2003
  ident: 298_CR18
  publication-title: J Neural Transm
  doi: 10.1007/s00702-002-0791-7
  contributor:
    fullname: MT Silva
– volume: 503
  start-page: 103
  year: 2004
  ident: 298_CR12
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2004.09.042
  contributor:
    fullname: D Klamer
– volume: 14
  start-page: 243
  year: 1993
  ident: 298_CR19
  publication-title: Synapse
  doi: 10.1002/syn.890140307
  contributor:
    fullname: R Spanagel
– volume: 151
  start-page: 99
  year: 2000
  ident: 298_CR21
  publication-title: Psychopharmacol
  doi: 10.1007/s002130000493
  contributor:
    fullname: LJMJ Vanderschuren
– volume: 4
  start-page: 199
  year: 1982
  ident: 298_CR9
  publication-title: Neurochem Int
  doi: 10.1016/0197-0186(82)90055-9
  contributor:
    fullname: U Havemann
– volume: 151
  start-page: 273
  year: 2000
  ident: 298_CR3
  publication-title: Psychopharmacol
  doi: 10.1007/s002130000447
  contributor:
    fullname: A Badiani
– volume: 499
  start-page: 108
  year: 1989
  ident: 298_CR22
  publication-title: Brain Res
  doi: 10.1016/0006-8993(89)91140-2
  contributor:
    fullname: P Vezina
– volume: 16
  start-page: 137
  year: 1994
  ident: 298_CR10
  publication-title: Synapse
  doi: 10.1002/syn.890160207
  contributor:
    fullname: M Jeziorski
– volume: 109
  start-page: 267
  year: 2002
  ident: 298_CR17
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(01)00483-3
  contributor:
    fullname: S Scheggi
– volume: 14
  start-page: 7415
  year: 1994
  ident: 298_CR4
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.14-12-07415.1994
  contributor:
    fullname: DM Bannerman
– volume: 458
  start-page: 119
  year: 2003
  ident: 298_CR6
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(02)02696-1
  contributor:
    fullname: A Gholami
– ident: 298_CR15
– volume: 28
  start-page: 755
  year: 1981
  ident: 298_CR16
  publication-title: Life Sci
  doi: 10.1016/0024-3205(81)90157-0
  contributor:
    fullname: RM Post
– volume: 362
  start-page: 232
  year: 2000
  ident: 298_CR1
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/s002100000287
  contributor:
    fullname: I Afanas’ev
– volume: 44
  start-page: 227
  year: 2002
  ident: 298_CR23
  publication-title: Synapse
  doi: 10.1002/syn.10076
  contributor:
    fullname: AR West
– volume: 482
  start-page: 205
  year: 2003
  ident: 298_CR25
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2003.10.006
  contributor:
    fullname: MR Zarrindast
– volume: 74
  start-page: 441
  year: 2001
  ident: 298_CR14
  publication-title: Physiol Behav
  doi: 10.1016/S0031-9384(01)00588-1
  contributor:
    fullname: K Park
– volume: 449
  start-page: 269
  year: 2002
  ident: 298_CR5
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(02)02038-1
  contributor:
    fullname: A Gholami
– volume: 54
  start-page: 679
  year: 1998
  ident: 298_CR24
  publication-title: Prog Neurobiol
  doi: 10.1016/S0301-0082(97)00090-7
  contributor:
    fullname: ME Wolf
– volume: 14
  start-page: 611
  year: 1975
  ident: 298_CR2
  publication-title: Neuropharmacol
  doi: 10.1016/0028-3908(75)90129-X
  contributor:
    fullname: M Babbini
– volume: 355
  start-page: 531
  year: 1997
  ident: 298_CR13
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/PL00004979
  contributor:
    fullname: A-K Lienau
– volume: 369
  start-page: 228
  year: 2004
  ident: 298_CR7
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/s00210-003-0855-8
  contributor:
    fullname: M Grönig
– volume: 7
  start-page: 169
  year: 1996
  ident: 298_CR20
  publication-title: Behav Pharmacol
  contributor:
    fullname: TM Tzschentke
– volume: 75
  start-page: 881
  year: 1996
  ident: 298_CR8
  publication-title: Neuroscience
  doi: 10.1016/0306-4522(96)00313-2
  contributor:
    fullname: H Hara
– volume: 5
  start-page: 48
  year: 1990
  ident: 298_CR11
  publication-title: Synapse
  doi: 10.1002/syn.890050104
  contributor:
    fullname: PW Kalivas
SSID ssj0001178
ssj0053170
ssj0053176
Score 1.9266286
Snippet The sensitization to the pharmacological actions of morphine is probably a critical factor in the addictive properties of this drug. A discrimination between...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 1
SubjectTerms Animals
Conditioning, Operant - drug effects
Conditioning, Operant - physiology
Dose-Response Relationship, Drug
Excitatory Amino Acid Antagonists - pharmacology
Male
Morphine - pharmacology
Motor Activity - drug effects
Motor Activity - physiology
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase - physiology
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate - physiology
Title Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine
URI https://www.ncbi.nlm.nih.gov/pubmed/15843868
https://www.proquest.com/docview/217839154
https://search.proquest.com/docview/19277244
https://search.proquest.com/docview/67588275
Volume 113
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sILAsaljIsfEA9UrhInTdLHCgoT07qXTRpPkR07TEJLpiVF234aEv-Nc2zntlHEeIlSx3VdnS_n4vP5mJC3SZhHWeD7LFeYZpxxyRKehQwmrYTOI8VNuaaDVbR3HH45mZ2MRr96rKV1LafZ9R_3lfyPVKEN5Iq7ZO8g2XZQaIB7kC9cQcJw_ScZLzsyhgSj9F0oswLwDX5TgCeqJ6uDj4sJ6DR9bg7VKU1KYHWIdQrqU4HL-JblqDrq0MTRDvWlo8gaf1I0UvyBB0FNirJg_aYKafC129KJ7izMBml-yNDMmgPU0NM9K0GuTSr_tk-MpUKwYAAaUABg1SMJLGpc8jeqbNrlnyqkgrr13_3pxiUMt3XL8xgEanZlQVtNDH4cAzUeDFS13bc6wKRVvH7Pglue7C3bYOkgFRY44gwLsGL1eeZ1hrBJ_t-wjy1rsa3wbIZIYYgUh0i9e2Sbg54DBbu9-Px1f9m6Ar4ftzktUHaoGrsPNo3u_nmTcPdMfdvhDIcu04Y4yPhDRw_JAyc0urCofERGunhMdhaFqMuzK_qOGmqxydnskJ8OqLTMaQNUvG-BShGotAUqLS_w8eqQNkClZUEBlbQHVOyETR1Q8Ts9VGKHG0ClA6DSuqQtUGkHVCqvaAPUJ-T40_Lowx5zh4awLJjFNZNxoD0R5xCqSxlCcB5JBT6qnqu5p8PIE1keKzlHyyO5ijOVadBHSTaPecRzrYOnZAvmpp8TGmotZl6kwzyBqCEQMHScRx6PFZ7Np_iYvG_kkp7b2jDpRoyMyW4judSpkCrlgA88oSEckzftU3i9MGknCl2uqxQiMAiAw7_0wJA_4fFsTJ5ZQHSTgegiSKLkxV0mukvud-_oS7JVX6z1K3C8a_nawfs3HyrcZA
link.rule.ids 315,783,787,27936,27937
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+blockade+of+glutamate+NMDA+receptors+or+of+NO+synthase+on+the+development+or+the+expression+of+associative+or+non-associative+sensitization+to+locomotor+activation+by+morphine&rft.jtitle=Journal+of+Neural+Transmission&rft.au=Atalla%2C+A.&rft.au=Kuschinsky%2C+K.&rft.date=2006-01-01&rft.issn=0300-9564&rft.eissn=1435-1463&rft.volume=113&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1007%2Fs00702-005-0298-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00702_005_0298_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9564&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9564&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9564&client=summon